3 completed, 2 terminated. 5 Phase 2, 4 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Terminated 2 |
| Phase 1 | 4 | Completed 3, Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Sumitomo Pharma Co., Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Trial to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic People With Schizophrenia, Followed by an Open-label Extension Phase SEP-363856 50 mg, SEP-363856 75 mg, Placebo - Schizophrenia | Phase 2 / Phase 3 | Terminated | Sumitomo Pharma Co., Ltd. | 83 | 2021-03-29 | 2024-03-15 |
| Special Combination of BBI608 and Pembrolizumab Napabucasin, Pembrolizumab - Metastatic Colorectal Cancer | Phase 1 / Phase 2 | Terminated | Takayuki Yoshino | 55 | 2016-10-01 | 2021-09-05 |
| A Study of DSP-7888 in Pediatric Patients With Relapsed or Refractory High Grade Gliomas DSP-7888 - Glioblastoma, Diffuse Intrinsic Pontine Glioma | Phase 1 / Phase 2 | Completed | Sumitomo Pharma Co., Ltd. | 18 | 2016-04-01 | 2022-04-12 |
| Study of DSP-7888 in Patients With Myelodysplastic Syndrome DSP-7888 - Myelodysplastic Syndrome | Phase 1 / Phase 2 | Completed | Sumitomo Pharma Co., Ltd. | 48 | 2015-05-01 | 2022-04-12 |
| A Study of BBI608 in Combination With Pemetrexed and Cisplatin in Adult Patients With Malignant Pleural Mesothelioma BBI608, Pemetrexed, Cisplatin - Malignant Pleural Mesothelioma, Non-Small Cell Lung Cancer | Phase 1 / Phase 2 | Completed | Sumitomo Pharma Co., Ltd. | 28 | 2015-02-01 | 2022-04-12 |
Carcinoma, Non-Small-Cell Lung (1) · Colorectal Neoplasms (1) · Diffuse Intrinsic Pontine Glioma (1) · Glioblastoma (1) · Glioma (1) · Mesothelioma, Malignant (1) · Myelodysplastic Syndromes (1) · Schizophrenia (1)
napabucasin (2) · Cisplatin (1) · Pemetrexed (1) · SEP-363856 (1) · pembrolizumab (1)
Japan (5) · China (1) · Philippines (1) · Taiwan (1)